Tablo® Hemodialysis System Receives FDA Clearance for Home Dialysis
The Food and Drug Administration cleared the Tablo Hemodialysis System for patient use in the home. The new home clearance expands Tablo's existing labeled indication for use in acute and chronic care facilities, which for the first time enables healthcare providers the same dialysis machine from the ICU to the home.
Signatera Technology for Personalized Monitoring in Gastrointestinal Cancer Shows Benefits According to a New Study
A new, peer-reviewed case study published in JCO Precision Oncology1 demonstrates the unique ability of Signatera technology to detect esophageal cancer recurrence almost one year before current standards of care, using a simple blood draw to monitor for traces of circulating tumor DNA.
AMRA Medical and Fulcrum Therapeutics Develop MRI Method for Multi-site Neuromuscular Clinical Trials
In collaboration, AMRA Medical and Fulcrum Therapeutics created a standardized whole-body magnetic resonance imaging (MRI) protocol to evaluate skeletal muscle composition in patients with facioscapulohumeral dystrophy (FSHD) – a slowly progressing muscular dystrophy. An abstract describing this work was accepted and made publicly available by the Muscular Dystrophy Association.
Jay M Moyes Appointed New CFO of Sera Prognostics
Jay M Moyes joins Sera Prognostics as it transitions from rigorous scientific and groundbreaking clinical stage company into a rapidly growing commercial organization.
Scopio Labs Receives CE Mark for X100 Microscope and Decision Support System With Full Field Peripheral Blood Smear (PBS) Application
Scopio Labs, to date, has demonstrated accurate results on hundreds of patient samples in Tel Aviv Sourasky Medical Center – Ichilov Hospital.